Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Durability of the TearCare treatment effect in subjects with dry eye disease: Stage 3 of the Sahara randomized controlled trial.
Journal: Optometry and vision science : official publication of the American Academy of Optometry
Published: July 28, 2025
A Randomized, Controlled Trial Comparing Tearcare® and Cyclosporine Ophthalmic Emulsion for the Treatment of Dry Eye Disease (SAHARA) [Response To Letter].
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: March 11, 2024
Improved Signs and Symptoms of Dry Eye Disease for Restasis® Patients Following a Single Tearcare® Treatment: Phase 2 of the SAHARA Study.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: February 16, 2024
A Randomized, Controlled Trial Comparing Tearcare® and Cyclosporine Ophthalmic Emulsion for the Treatment of Dry Eye Disease (SAHARA).
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: October 25, 2023
A Comparison of TearCare and Lipiflow Systems in Reducing Dry Eye Disease Symptoms Associated with Meibomian Gland Disease.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: March 30, 2022
Dry Eye Treatment with Topical Cyclosporine 0.1% in Chondroitin Sulfate Ophthalmic Emulsion.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: February 25, 2021
TearCare for the Treatment of Meibomian Gland Dysfunction in Adult Patients With Dry Eye Disease: A Masked Randomized Controlled Trial.
Journal: Cornea
Published: January 21, 2021
Showing 1-7 of 7
Last Updated: 09/26/2026